Surgical Critical Care: Acute Respiratory Distress Syndrome (ARDS)

Acute Respiratory Distress Syndrome (ARDS)

Berlin Criteria Mn

  • Bilateral Opacities on Imaging
  • Acute Onset < 7 Days
  • PaO2:FiO2 < 300
  • Not Fully Explained by CHF or Fluid Overload

Severity

  • *Based on PaO2:FiO2 (P:F Ratio)
  • Mild: P:F < 300
  • Moderate: P:F < 200
  • Severe: P:F < 100

Mortality

  • Overall High Mortality (40%)
  • Increases with Disease Severity
    • Mild: 35%
    • Moderate: 40%
    • Severe: 46%

Causes

  • Sepsis (Most Common Cause)
  • Pneumonia (Most Common Community-Acquired Cause)
  • Aspiration
  • Trauma
  • Massive Transfusion/Transfusion-Related Acute Lung Injury (TRALI)
  • Pancreatitis
  • Inhalation Injury
  • Cardiothoracic Surgery
  • Medications

Presentation

  • Dyspnea
  • Altered Mental Status
  • Respiratory Distress
  • Complications:
    • Impaired Gas Exchange & Hypoxemia
      • Most Common Long-Term Defect: Decreased Diffusion Capacity
    • Decreased Lung Compliance
    • Barotrauma
    • Pulmonary Hypertension

Phases

  • 1st Phase: Exudative Phase
    • Diffuse Alveolar Damage (DAD) Over the First 7-10 Days
    • Effects:
      • Necrosis & Sloughing of Type I Pneumocytes & Capillary Endothelium
        • Loss of Tight Junctions that Prevent Fluid Movement
      • Inflammatory Exudate (Protein Rich) Floods Alveoli – From Increased Vascular Permeability
      • Lung Injury – From Leukocyte Proliferation
      • Collapse & Shunting – From Surfactant Inhibition
      • Hyaline Membrane Forms within Alveoli
  • 2nd Phase: Fibroproliferative Phase
    • Proliferation of Type II Pneumocytes After 7-10 Days
    • Generally Lasts About 14-21 Days
    • Effects:
      • Early Collagen Formation
      • Interstitial Infiltration of Myofibroblasts
      • Decreased Compliance
    • Still Reversible
  • 3rd Phase: Fibrotic Phase
    • Interstitial Fibrosis
    • Not a Universal Outcome Seen in All Patients
    • Associated with & Prolonged Mechanical Ventilation & Increased Mortality

Diagnosis

  • Diagnosis: Clinical Diagnosis Based on the Berlin Criteria (Above)

ARDS 1

Acute Respiratory Distress Syndrome (ARDS) – Treatment

Primary Treatment

  • Supportive Care
    • Treat Underlying Pathology
    • Conservative Fluid Management
      • Improves Ventilator-Free & ICU-Free Days
      • No Mortality Benefit
    • Manage Patient-Ventilator Dyssynchrony
  • Lung Protective Ventilation

Lung Protective Ventilation

  • Definition: Ventilation with Low Tidal Volumes to Reduce Alveolar Overdistention & Barotrauma
  • Improves Mortality for ARDS of All Severities
  • Ventilation (Tidal Volume/Respiratory Rate)
    • Initially Tidal Volume: 8 ml/kg x Ideal Body Weight (General Standard)
    • Decrease Tidal Volume 1 ml/kg Every 1-2 Hours
    • Goal Tidal Volume: 4-6 ml/kg x Ideal Body Weight
    • Adjust Tidal Volume & Respiratory Rate for Goal Plateau Pressure ≤ 30 cm H2O
  • Oxygenation (PEEP/FiO2)
    • Oxygenation Goals: PaO2 55-80 mmHg or SpO2 88-95%
    • Adjust PEEP to Required FiO2
    • Initially Recommended to Start with Lower-PEEP Strategy
FiO2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
PEEP 5 5-8 8-10 10 10-14 14 14-18 18-24
    • Consider High-PEEP Strategy if Refractory
FiO2 0.3 0.4 0.5 0.6-0.7 0.8-0.9 1.0
PEEP 5-14 14-16 16-18 20 22 22-24

Ancillary Measures

Mnemonics

Berlin Criteria for ARDS

  • “ABC-3”
    • Acute
    • Bilateral Opacities
    • CHF Not Fully Explained
    • P:F < 300

References

  1. Santos LC, Abreu CF, Xerinda SM, Tavares M, Lucas R, Sarmento AC. Severe imported malaria in an intensive care unit: a review of 59 cases. Malar J. 2012 Mar 29;11:96. (License: CC BY-2.0)